Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
crispr
5
×
life sciences
national blog main
san francisco blog main
5
×
boston top stories
deals
national top stories
san francisco top stories
startups
abbvie
allergan
boulder/denver blog main
boulder/denver top stories
cancer
clinical trials
detroit blog main
detroit top stories
editas medicine
fda
indiana blog main
indiana top stories
ipo
medical devices
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alzheimer's disease
cancer immunotherapy
What
bio
roundup
develop
life
mammoth
medicines
science
abbvie
acquisitions
alliance
announced
available
bails
based
big
biosciences
biotech
black
brand
bridgebio
capital
car
cas
ceo
cheaper
collabs
companies
continue
covid
crispr
daniel
deal
debut
diagnostics
diamond
diamond’s
drugs
editas
editing
emerges
Language
unset
5
×
Current search:
crispr
×
unset
×
" san francisco blog main "
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More